Copyright © 2000 by the European Society of Cardiology.
Hotline Editorial
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
The Cleveland Clinic Foundation, Cleveland, Ohio, U. S. A
References
- Hinohara T, Selmon MR, Robertson GC, Braden L, Simpson JS. Directional atherectomy: New approaches for treatment of obstructive coronary and peripheral vascular disease. Circulation. 1990;81:IV79
- Topol EJ, Leya F, Pinkerton CA. A comparison of coronary angioplasty with directional atherectomy in patients with coronary artery disease. N Engl J Med. 1993;329:221227
[Abstract/Free Full Text] - Adelman AG, Cohen EA, Kimball BP. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993;329:228233
[Abstract/Free Full Text] - Omoigui NA, Silver MJ, Rubicki LA. Influence of a randomized clinical trial on practice by participating investigators: lessons from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). CAVEAT I and II Investigators. J Am Coll Cardiol. 1998;31:273274
[Free Full Text] - Fischman DL, Leon MB, Baim DS. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496501
[Abstract/Free Full Text] - Serruys PW, de Jaegere P, Kiemeneij F. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489495
[Abstract/Free Full Text] - N Engl J Med. 1994;330:956961
[Abstract/Free Full Text] - N Engl J Med. 1997;336:16891696
[Abstract/Free Full Text] - Lancet. 1997;349:14291435[CrossRef][ISI][Medline]
- Brener SJ, Barr LA, Burchenal JEB. A randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation. 1998;98:734741
[Abstract/Free Full Text] - Lancet. 1998;352:8792[ISI][Medline]
- Lincoff AM, Califf RM, Moliterno DJ. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. New Engl J Med. 1999;341:319327
[Abstract/Free Full Text] - Stein B, Weintraub WS, Gebhart SSP. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979989
[Abstract/Free Full Text] - Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:18181825
[Abstract/Free Full Text] - N Engl J Med. 1996;335:217225
[Abstract/Free Full Text] - Lancet. 1997;349:14221428[CrossRef][ISI][Medline]
- Bittl JA, Strony J, Brinker JA. Treatment with Bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med. 1995;333:764769
[Abstract/Free Full Text] - Serruys PW, Herrman J-PR, Simon R. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1995;333:757763
[Abstract/Free Full Text] - Weintraub WS, Boccuzzi SJ, Klein L. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med. 1994;331:13311337
[Abstract/Free Full Text] - Circulation. 1997;96:14451453
[Abstract/Free Full Text] - Topol EJ, Ferguson JJ, Weisman HF. Long-term protection from myocardial ischemic events in a randomized trial of brief integrin ß3 blockade with percutaneous coronary intervention. JAMA. 1997;278:479484[Abstract]
- Lincoff AM, Tcheng JE, Califf RM. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one year outcome in the EPILOG trial. Circulation. 1999;99:19511958
[Abstract/Free Full Text] - Neumann FJ, Blasini R, Schmitt C. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction. Circulation. 1999;98:26952701
- Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG. Significance of mild transient release of creatine kinaseMB fraction after percutaneous coronary intervention. Circulation. 1996;94:15281536
[Abstract/Free Full Text] - Kugelmass AD, Cohen CJ, Moscucci M. Elevation in creatine kinase myocardial isoform following otherwise successful directional coronary atherectomy and stenting. Am J Cardiol. 1994;74:748754[CrossRef][ISI][Medline]
- Harrington RA, Lincoff AM, Califf RM. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the coronary angioplasty versus excisional atherectomy trial (CAVEAT). J Am Coll Cardiol. 1995;25:16931699[Abstract]
- Kong TQ, Davidson CJ, Meyers SN, Tauke JT, Parker MA, Bonow RO. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA. 1997;277:461466[Abstract]
- Tardiff BE, Califf RM, Tcheng JE. Post-intervention cardiac enzyme elevations: prognostic significance in IMPACT-II (abstr). J Am Coll Cardiol. 1996;27:83A
- Redwood SR, Popma JJ, Kent KK. Predictors of late mortality following ablative new-device angioplasty in native coronary arteries (Abstr). J Am Coll Cardiol. 1996;27:167A
- Lincoff AM, Califf RM, Anderson KM. Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by c7E3 Fab (abciximab) among patients with unstable angina undergoing percutaneous coronary revascularization. J Am Coll Cardiol. 1997;30:149156[Abstract]
- Kereiakes DJ, Lincoff AM, Miller DP. Abciximab therapy and unplanned coronary stent deployment. Favorable effects on stent use, clinical outcomes, and bleeding complications. Circulation. 1998;97:857864
[Abstract/Free Full Text] - Hamm C, Heeschen C, Goldmann B. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 1999;340:16231629
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
D. J. Francis, C. R. Parish, M. McGarry, F. S. Santiago, H. C. Lowe, K. J. Brown, J. A. Bingley, I. P. Hayward, W. B. Cowden, J. H. Campbell, et al. Blockade of Vascular Smooth Muscle Cell Proliferation and Intimal Thickening After Balloon Injury by the Sulfated Oligosaccharide PI-88: Phosphomannopentaose Sulfate Directly Binds FGF-2, Blocks Cellular Signaling, and Inhibits Proliferation Circ. Res., May 2, 2003; 92 (8): e70 - e77. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
